Skip to main content
. 2018 Jan 25;8:1603. doi: 10.1038/s41598-017-16703-9

Figure 6.

Figure 6

Drug delivery of ND-EFV through BBB in vitro. ND-EFV (green) and FD (blue) (40 µg/ml) were introduced separately in the upper chamber of in vitro BBB model. EFV drug release was observed at different time points (30 min – Day 2) at the lower chamber of BBB model. A comparative analysis of sustained drug release from ND-EFV vs. FD through BBB was monitored with a drug content of the media with respect to time. Each set of drug release study was done in three replicates and data were represented with the statistical significance (p > 0.0001).